KRAS and metastatic colorectal cancer: Similarly, FOLFIRI is also being tested in combination with the virus based investigative therapy REOLYSIN and bevacizumab in FOLFIRI naïve patients with KRAS mutant metastatic colorectal cancer (Clinicaltrials.gov Identifier: NCT01274624 (accessed on 24 February 2021)).